Research Article| Volume 115, ISSUE 1, P7-13, January 31, 2007

Download started.


A novel haplotype in ABCA1 gene effects plasma HDL-C concentration


      Background and objectives

      ATP-binding cassette transporter 1 (ABCA1) is a trans-membrane protein responsible for the efflux of cholesterol and phospholipids across the cell membrane, an essential step in the reverse cholesterol transport system. This study investigates the effect of five non-synonymous SNPs of ABCA1 gene on plasma HDL-C levels in Pakistani individuals free of ischemic heart disease and stroke.


      Five non-synonymous SNPs were selected after sequencing ABCA1 gene in patients of Hypoalphalipoproteinemia. The presence of these SNPs was then checked in 200 individuals by using PCR-RFLP. Plasma glucose and lipid fractions were measured in fasting state. Ethical approval was obtained from the Ethical Review Committee, Aga Khan University and informed consent was obtained from all subjects.


      LL genotype of V825L polymorphism was associated with decreased levels of HDL-C [−0.17 (−0.32 to −0.19); P=0.02] and P774 allele showed a significant increase in HDL-C levels as compared to T774 allele [−0.15 (−0.18 to −0.02); P=0.01]. R219K, A399V and V771M polymorphisms did not show any association with levels of HDL-C, LDL-C, cholesterol and triglycerides. Haplotype analysis between R219K and V825L polymorphisms showed a unique interaction between R219 allele and L825 allele. The RL haplotype was found to be associated with decreased levels of HDL-C [−0.12 (−0.22 to −0.03); P=0.001].


      ABCA1 polymorphisms are associated with varying levels of HDL-C in Pakistani individuals. These results warrant further investigations as ABCA1 polymorphisms may have a major role in the high incidence of cardiovascular disorders in South Asians.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Abbott R.D.
        • Wilson P.W.
        • Kannel W.B.
        • Castelli W.P.
        High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study.
        Arteriosclerosis. 1988 (May–Jun); 8: 207-211
        • Miller M.
        • Mead L.A.
        • Kwiterovich Jr., P.O.
        • Pearson T.A.
        Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease.
        Am J Cardiol. 1990 (Jan 1); 65: 1-5
        • Miller M.
        • Seidler A.
        • Kwiterovich P.O.
        • Pearson T.A.
        Long-term predictors of subsequent cardiovascular events with coronary artery disease and ‘desirable’ levels of plasma total cholesterol.
        Circulation. 1992 (Oct); 86: 1165-1170
        • Attie A.D.
        • Kastelein J.P.
        • Hayden M.R.
        Pivotal role of ABCA1 in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis.
        J Lipid Res. 2001 (Nov); 42: 1717-1726
        • Cockerill G.W.
        • Huehns T.Y.
        • Weerasinghe A.
        • et al.
        Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation.
        Circulation. 2001 (Jan 2); 103: 108-112
        • Dimayuga P.
        • Zhu J.
        • Oguchi S.
        • et al.
        Reconstituted HDL containing human apolipoprotein A-1 reduces VCAM-1 expression and neointima formation following periadventitial cuff-induced carotid injury in apoE null mice.
        Biochem Biophys Res Commun. 1999 (Oct 22); 264: 465-468
        • Nofer J.R.
        • Levkau B.
        • Wolinska I.
        • et al.
        Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids.
        J Biol Chem. 2001 (Sep 14); 276: 34480-34485
        • Nofer J.R.
        • Kehrel B.
        • Fobker M.
        • Levkau B.
        • Assmann G.
        • von Eckardstein A.
        HDL and arteriosclerosis: beyond reverse cholesterol transport.
        Atherosclerosis. 2002 (Mar); 161: 1-16
        • Navab M.
        • Hama S.Y.
        • Anantharamaiah G.M.
        • et al.
        Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
        J Lipid Res. 2000 (Sep); 41: 1495-1508
        • Navab M.
        • Hama S.Y.
        • Hough G.P.
        • et al.
        High density associated enzymes: their role in vascular biology.
        Curr Opin Lipidol. 1998 (Oct); 9: 449-456
        • Prenger V.L.
        • Beaty T.H.
        • Kwiterovich P.O.
        Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catheterization patients.
        Am J Hum Genet. 1992 (Nov); 51: 1047-1057
        • Friedlander Y.
        • Kark J.D.
        • Stein Y.
        Biological and environmental sources of variation in plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic.
        Hum Hered. 1986; 36: 143-153
        • Bucher K.D.
        • Friedlander Y.
        • Kaplan E.B.
        • et al.
        Biological and cultural sources of familial resemblance in plasma lipids: a comparison between North America and Israel—the Lipid Research Clinics Program.
        Genet Epidemiol. 1988; 5: 17-33
        • Hunt S.C.
        • Hasstedt S.J.
        • Kuida H.
        • Stults B.M.
        • Hopkins P.N.
        • Williams R.R.
        Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins.
        Am J Epidemiol. 1989 (Mar); 129: 625-638
        • Tall A.R.
        • Breslow J.L.
        • Rubin E.M.
        Genetic disorders affecting plasma high-density lipoproteins.
        in: Scriver C.R Beaudet A.L. Sly W.S. Valle D. The metabolic and molecular bases of inherited disease. 8th edition. McGraw-Hill, New York, NY, USA2001: 2915-2936
        • Bodzioch M.
        • Orso E.
        • Klucken J.
        • et al.
        The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.
        Nat Genet. 1999; 22: 347-351
        • Klein I.
        • Sarkadi B.
        • Varadi A.
        An inventory of the human ABC proteins.
        Biochim Biophys Acta. 1999; 1461: 237-262
        • Schmitz G.
        • Langmann T.
        Structure, function and regulation of the ABC1 gene product.
        Curr Opin Lipidol. 2001; 12: 129-140
        • Langmann T.
        • Klucken J.
        • Reil M.
        • et al.
        Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.
        Biochem Biophys Res Commun. 1999; 257: 29-33
        • Bisoendial R.J.
        • Hovingh G.K.
        • Levels J.H.
        • et al.
        Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein.
        Circulation. 2003; 107: 2944-2948
        • Frikke-Schmidt R.
        • Nordestgaard B.G.
        • Jensen G.B.
        • Tybjaerg-Hansen A.
        Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population.
        J Clin Invest. 2004 (Nov); 114: 1343-1353
        • Cohen J.C.
        • Kiss R.S.
        • Pertsemlidis A.
        • Marcel Y.L.
        • McPherson R.
        • Hobbs H.H.
        Multiple rare alleles contribute to low plasma levels of HDL cholesterol.
        Science. 2004 (Aug 6); 305: 869-872
        • Clee S.M.
        • Zwinderman A.H.
        • Engert J.C.
        • et al.
        Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease.
        Circulation. 2001 (Mar 6); 103: 1198-1205
        • Singh Rb.
        • Niaz M.A.
        Coronary heart disease in Indians, Pakistanis and Bangladeshis: aetiology and possibilities for prevention.
        Br Heart J. 1993; 69: 572
        • Saleheen D.
        • Nazir A.
        • Khanum S.
        • Haider S.R.
        • Frossard P.M.
        R1615P: a novel mutation in ABCA1 associated with low levels of HDL and type II diabetes mellitus.
        Int J Cardiol. 2005 (July 28);
        • Lapicka-Bodzioch K.
        • Bodzioch M.
        • Krull M.
        • et al.
        Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome.
        Biochim Biophys Acta. 2001; 1537: 42-48
        • Tregouet D.A.
        • Barbaux S.
        • Escolano S.
        • et al.
        Specific haplotypes of the P-selectin gene are associated with myocardial infarction.
        Hum Mol Genet. 2002; 11: 2015-2023
        • Singaraja R.R.
        • Brunham L.R.
        • Visscher H.
        • Kastelein J.J.
        • Hayden M.R.
        Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene.
        Arterioscler Thromb Vasc Biol. 2003 (Aug 1); 23: 1322-1332
        • Drysdale C.M.
        • McGraw D.W.
        • Stack C.B.
        • et al.
        Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness.
        Proc Natl Acad Sci U S A. 2000; 97: 10483-10488
        • Costet P.
        • Luo Y.
        • Wang N.
        • Tall A.R.
        Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor.
        J Biol Chem. 2000; 275: 28240-28245
        • Chinetti G.
        • Lestavel S.
        • Bocher V.
        • et al.
        PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.
        Nat Med. 2001; 7: 53-58
        • Joseph S.B.
        • McKilligin E.
        • Pei L.
        • et al.
        Synthetic LXR ligand inhibits the development of atherosclerosis in mice.
        Proc Natl Acad Sci U S A. 2002; 99: 7604-7609
        • Miao B.
        • Zondlo S.
        • Gibbs S.
        • et al.
        Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator.
        J Lipid Res. 2004; 45: 1410-1417
        • Schaefer E.J.
        • Lamon-Fava S.
        • Ordovas J.M.
        • et al.
        Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.
        J Lipid Res. 1994; 35: 871-882
        • Stone N.J.
        Secondary causes of hyperlipidemia.
        Med Clin North Am. 1994; 78: 117-141
        • Clee S.M.
        • Zwinderman A.H.
        • Engert J.C.
        • et al.
        Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease.
        Circulation. 2001; 103: 1198-1205